Recent Posts

Post thread…


Company car medical exception? - AbbVie

  • anonymous said:
    What kind of medical exceptions and documentation will get me the larger company car with out having to pay the additional $300
    Click to expand...
    Fleet will give you the email to start the process. You will need Medical Records, Chiropractic works as ell, and then get measured by a Phsical Therapist. Its a process, but it works.

anonymous
May 17, 2025 at 08:45 AM
Kenvue Live! So fake! - Kenvue

  • anonymous said:
    I can’t wait to see the Dan Loeb letter from third point on all the wasteful spending Thibaut is doing. Right down to Summit itself just so his wife could keep living in nyc - when they could have got a huge tax brake moving elsewhere.
    Click to expand...
    They actually owned the other two sites, and could have sold one and moved into the other with space to spare. Now Fort Washington is going to sit empty to keep manufacturing on the other side of the building.

anonymous
May 17, 2025 at 08:37 AM
CEO sacking - Novo Nordisk

  • anonymous said:
    The failure here is not the recent performance that resulted in the stock decline but rather the decisions that were made years ago that severely underestimated the potential of semaglutide in obesity. Had the company really known what they had, we wouldn’t be in the no-win situation we are in now.

    We would’ve had supply from the start. We would gained preference earlier. It would have taken years not months for Zepbound to take over.

    Lars himself admitted as much a couple years ago during the peak of our supply issues. We are a diabetes company and we looked at Wegovy and obesity as a nice little add on. We totally underestimated the paradigm shifting potential that GLP-1 had.

    Since that decision we made mis-step after mis-step. We thought our way of doing it was the right away and neglected to innovate and all the while Lilly just kept marching on.

    You don’t need thousands of reps selling Wegovy. We launched it with a couple hundred. What you needed was supply. Support. Access. Innovation.

    But now it’s all too late. Nothing can be done now to change the trajectory of both Ozempic and Wegovy. The best we can do is hope that CagriSema or another asset we’ve acquired can compete.

    But again, Lilly is light years ahead of us in pipeline and their next generation meds look better than our own.

    Love Novo as a company, but I fear for our future.
    Click to expand...
    What will change the trajectory is when The Surpass-CVOT failure for Mounjaro

anonymous
May 17, 2025 at 08:37 AM
Brace Yourselves SURPASS CVOT - Eli Lilly

  • I fully expect for the results to be released on a national holiday when markets are closed, Will it be Juneteeth or July 4? Even as 67,000 people have viewed this thread not a single person has offered any counter argument saying the results are positive. That says it all! What could the fall out be if the results are really really bad?

anonymous
May 17, 2025 at 08:31 AM
Market Access NBM - Bayer

  • We have quite an intriguing situation! To summarize, we've recently seen the departure of three of our top account managers; this year’s award winners?!? This is quite a shake-up for the team. The latest exit is especially noteworthy; it’s the National Account Director (NAD) who was just a few weeks ago extolling the virtues of Bayer as an exemplary workplace on a panel. It’s almost laughable to think about it in light of their abrupt departure. The entire NAD team and more than half the RAD team interviewing for new jobs!!! Honestly, navigating the daily challenges here feels like it demands a good sense of humor just to withstand the storms we face. The unfortunate truth is that our leadership is clearly floundering without a clear sense of direction or support, leaving many of us feeling adrift and uninspired. Makes you wonder if they even care or are looking for new jobs as well?

anonymous
May 17, 2025 at 08:20 AM
Top Bottom
Back
Post thread…